In this work, we uncover an impaired AKT/GSK‐3β/NRF2 axis in X‐ALD, composed of a blunted NRF2‐dependent response which obeys an aberrant upstream activation of GSK‐3β. The gene discussed is GSK3B; the disease is adrenoleukodystrophy.